TEOSYAL® PURESENSE REDENSITY I (1x3ml)

Teosyal Puresense Redensity I (1x3ml) Main Ingredients and Device Properties

The main ingredients of Teosyal Puresense Redensity I (1x3ml) include:

• Non-crosslinked hyaluronic acid (HA): A naturally occurring dermal filler substance in the skin that maintains hydration and volume.
• Lidocaine: A local anaesthetic for reducing injection pain.
• Amino acids: Lysine, Glycine, Proline, Leucine, Threonine, Valine, Isoleucine, and Arginine. Help in collagen production and skin regeneration.
• Antioxidants: N-acetyl-L-cysteine, Alpha Lipoic Acid, and Glutathione. Protect the skin from free radical damage.
• Vitamins and minerals: Zinc, Copper, and B6. Enhance skin health and vitality.

Device properties:

• Concentration: 15 mg/ml of hyaluronic acid.
• Volume: 3 ml per syringe.
• Sterile and single-use: Ensures maximum safety and hygiene.

Package Contains

The Teosyal Puresense Redensity I (1x3ml) package includes:

• 1 pre-filled syringe of 3ml.
• 2 sterile 30G1/2” needles.
• Package insert with instructions.
• Traceability labels.

Storage Conditions

Proper storage of Teosyal Puresense Redensity I (1x3ml) is essential to maintain its efficacy and safety. Here are the recommended storage conditions:

• Keep the product in its original packaging until use.
• Do not use after the expiry date indicated on the packaging.
• Store at a temperature between 2°C and 25°C.
• Protect from direct sunlight and freezing.

Mode of Administration

Administering Teosyal Puresense Redensity I (1x3ml) involves specific steps before, during, and after the procedure to ensure optimal results and patient safety.

Pre-procedure:

• Conduct a thorough patient assessment and obtain informed consent.
• Cleanse the treatment area with an antiseptic solution.
• Apply a topical anaesthetic if necessary to minimise discomfort.

During procedure:

• Use a sterile, disposable needle or cannula for injection.
• Inject the product slowly and evenly into the superficial to mid-dermis.
• Massage the treated area gently to ensure even distribution.

After procedure:

• Apply a cold compress to reduce swelling and bruising.
• Advise the patient to avoid touching or rubbing the treated area.
• Provide post-treatment care instructions to the patient.

Post-treatment Care

Post-treatment care is crucial to maximise the benefits of Teosyal Puresense Redensity I (1x3ml) and minimise potential side effects. Here are some recommendations you can offer your patients:

• Schedule a follow-up appointment to assess the treatment results and discuss any concerns.
• Avoid alcohol and blood-thinning medications for 24 hours.
• Avoid strenuous exercise and exposure to extreme temperatures for 24 hours.
• Do not apply makeup to the treated area for at least 12 hours.
• Use a gentle cleanser and moisturiser on the treated area.
• Protect the skin from direct sun exposure and use a high-SPF sunscreen.

Benefits and Results of Using Teosyal Puresense Redensity I (1x3ml)

Teosyal Puresense Redensity I (1x3ml) offers numerous benefits that enhance skin hydration, texture, and radiance, providing visible and long-lasting results, including:

• Hydrates skin deeply
• Improves skin texture
• Enhances skin elasticity
• Radiance boost
• Lidocaine ensures minimal discomfort
• Provides subtle, natural results
• Quick procedure
• Suitable for the face, neck, décolleté, and hands
• Early intervention can delay more significant ageing signs
• Enhances overall appearance, contributing to better self-esteem and confidence.

Potential Side Effects

While Teosyal Puresense Redensity I (1x3ml) is generally well-tolerated, some patients may experience side effects that range from common to rare.

Common side effects:

• Redness
• Swelling
• Bruising
• Itching
• Tenderness
• Pain at the injection site.

Rare side effects:

• Allergic reactions
• Infection
• Lumps or nodules
• Discolouration
• Granulomas
• Persistent swelling or pain
• Necrosis (extremely rare).

Contraindications for the Treatment

Certain conditions and circumstances may make patients unsuitable for Teosyal treatment, needing careful assessment by medical professionals:

• Pregnancy and breastfeeding
• Autoimmune diseases
• Hypersensitivity to hyaluronic acid or lidocaine
• Active skin infections or inflammation
• Blood clotting disorders
• Severe allergies or anaphylaxis history
• Recent skin procedures
• Unstable medical conditions
• Ongoing immunotherapy.

Medical professionals should conduct a thorough patient assessment and provide appropriate advice before administering the treatment.